It is nicely recognized that IL-two is a pleiotropic cytokine positioned for the crossroads of T cell activation and regulation. Therefore, it is actually crucial to engineer an IL-two molecule that may be biased to effector cells bearing the intermediate affinity receptor, including naïve and memory CD8+ T cells and NK cells, vs . Treg cells that